The European Commission is siding with MEPs, who want to use the unspent funds to boost health R&D in 2022. But the Commission is at odds with Parliament over demands for more control over the EU’s new health agency
As EU hangs tough on tying UK association in Horizon Europe to ending the dispute over the Northern Ireland Protocol, the UK government is dangling the funding carrot and says if there is no deal, it has a ‘bold’ plan B
Budget should double to ensure Europe can fund all excellent science Leptin says, as she takes the reins at the European Research Council on 1 November
In wide-ranging interview, the research commissioner outlines issues standing in the way of the UK and Switzerland taking part in Horizon Europe. There is also an update on the European Research Area and a call for one and all to back the research missions
€408M in the Horizon 2020 budget was not disbursed. MEPs say it could be used to reverse cuts to 2022 spending on research proposed by the European Council in July
Following objections from member states, the Commission has shifted position and after receiving assurances, now appears open to UK involvement in these strategic fields, while Israel will be allowed to take part in quantum research
EU health commissioner downplays concerns of ‘democratic deficiencies’ in the setup of HERA, as the European Parliament demands more transparency and a greater say in how the authority operates
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.